The Enterprise Value as of November 2024 (TTM) for RAPT Therapeutics, Inc. (RAPT) is 4.97M

According to RAPT Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.97M. This represents a change of -98.50% compared to the average of 331.66M of the last 4 quarters.

RAPT Therapeutics, Inc. (RAPT) Historical Enterprise Value (quarterly & annually)

How has RAPT Enterprise Value performed in the past?

The mean historical Enterprise Value of RAPT Therapeutics, Inc. over the last ten years is 579.62M. The current 4.97M Enterprise Value has changed -14.17% with respect to the historical average. Over the past ten years (40 quarters), RAPT's Enterprise Value was at its highest in in the December 2021 quarter at 1.06B. The Enterprise Value was at its lowest in in the September 2019 quarter at -37868023.00.

RAPT Therapeutics, Inc. (RAPT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RAPT Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RAPT Therapeutics, Inc. (RAPT) Average Enterprise Value

How has RAPT Enterprise Value performed in the past?

The current Enterprise Value of RAPT Therapeutics, Inc. (RAPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

RAPT Therapeutics, Inc. (RAPT) Enterprise Value vs. Peers

How is RAPT’s Enterprise Value compared to its peers?

RAPT Therapeutics, Inc.’s Enterprise Value is greater than Connect Biopharma Holdings Limited (-54594968.00), less than Tyra Biosciences, Inc. (703.47M), greater than Xilio Therapeutics, Inc. (-13633399.00), less than Mineralys Therapeutics, Inc. (523.81M), less than Molecular Partners AG (130.63M), less than AN2 Therapeutics, Inc. (6.48M), less than Pharvaris N.V. (850.00M), less than PepGen Inc. (120.50M), less than Monte Rosa Therapeutics, Inc. (439.72M), less than Design Therapeutics, Inc. (290.40M), greater than Werewolf Therapeutics, Inc. (-1378920.00), less than Ikena Oncology, Inc. (45.73M), less than Stoke Therapeutics, Inc. (457.69M), less than Anebulo Pharmaceuticals, Inc. (36.46M), less than PMV Pharmaceuticals, Inc. (47.77M), less than Eliem Therapeutics, Inc. (119.64M), less than HCW Biologics Inc. (34.47M), less than Relay Therapeutics, Inc. (692.53M), less than Pliant Therapeutics, Inc. (770.48M), less than Black Diamond Therapeutics, Inc. (139.97M), less than Arvinas, Inc. (1.69B),

Build a custom stock screener for RAPT Therapeutics, Inc. (RAPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RAPT Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RAPT Therapeutics, Inc. (RAPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RAPT Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.